Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0000950170-24-033814 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | TYRA | Harris Todd | Pres, CEO, Dir | A - Grant | $6.58 | +1,880 | 1.50M | +0.1% | +$12.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 1,880 | $6.58 | 1,504,577 | D | — | — |